Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 60 results for "cadila healthcare"

Cadila gets USFDA nod for generic drug to treat Parkinson#39;s disease
Money Control

Cadila gets USFDA nod for generic drug to treat Parkinson#39;s...

Cadila Healthcare said it has received approval from the US health regulator to market Pramipexole Dihydrochloride extended-release tablets, used for treating Parkinson#39;s disease, in the American market. Money Control, 4 days ago

48 images for cadila healthcare

Business Standard, 4 days ago
Business Standard, 1 week ago
Money Control, 1 month ago
Business Standard, 1 month ago
Money Control, 1 month ago
Money Control, 2 weeks ago
Business Standard, 1 month ago
Money Control, 1 month ago
Money Control, 2 months ago
Money Control, 1 month ago
Money Control

Cadila Healthcare shares gain on USFDA approval for Clozapine that treats schizophrenia

Clozapine tablets will be manufactured at group#39;s formulations manufacturing facility at SEZ, Ahmedabad.
 Money Control1 week ago Cadila Healthcare shares gain 4% on USFDA approval for ADHD drug  Money Control1 month ago
Money Control

Stocks in the news: Lupin, GAIL, ONGC, TVS Motor, Parsvanath, SpiceJet, Emami, Sonata

Lupin | Cadila Healthcare | GAIL | ONGC | Oil India | TTK Prestige | Union Bank | SAIL | TVS Motor | Parsvanath Developers | SpiceJet | Sonata Software | Emami | Suzlon Energy and Biocon are stocks, which are in the news today.
 Money Control1 week ago
Business Standard

Lupin, Cadila Healthcare recall drugs in US market

The ongoing voluntary nationwide recall is a class-III recall Press Trust of India | New Delhi Last Updated at December 8, 2017 01:53 IST Drug firms Lupin and Cadila Healthcare are recalling more than 100,000 units of Duloxetine delayed-release capsules and ...
 Business Standard1 week ago

Us Tax Reform Woes Dent Sentiment

Posted by Equitymaster Global financial markets ended the week on a mixed note after concern from investors over potential obstacles to Republican's tax overhaul and a slate of policy meetings from major central banks in Europe. In the US, uncertainty over ...
 Equitymaster.com2 days ago

Of Protection on Bank Deposits, Business Confidence, and Other Top Cues in Focus Today

Posted by Equitymaster Indian share markets witnessed buying interest in yesterday's session and finished firm at closing prices. At the closing bell yesterday, the BSE Sensex closed higher by 205 points and the NSE Nifty finished higher by 57 points. The S&P ...
 Equitymaster.com6 days ago US Tax Bill; Flynn Plea; Automobile Stocks & Other Top Cues to Sway Markets Today  Equitymaster.com2 weeks ago World Stocks Positive as US Fed Looks to Raise Rates  Equitymaster.com3 weeks ago Insurance Stocks Tumble on Fears of Higher Tax; ECB Minutes in Focus; & Other Top Cues in Action Today  Equitymaster.com3 weeks ago

Gujarat Elections; Strong Global Markets; Axis Bank & Stocks to Sway the Market Today

Posted by Equitymaster Indian share markets extended rally in afternoon trade. The buying momentum was backed by hopes that the ruling Bharatiya Janata Party (BJP) would win critical state elections in Gujarat beginning this weekend, while automakers gained ...
 Equitymaster.com1 week ago Strong Global Markets; Oil Prices; M&M;, RIL & Stocks to Sway the Market Today  Equitymaster.com3 weeks ago

'We are a consumption-based economy, demand will not go away easily'

For India Inc, latest GDP figures signal a turnaround. Corporate houses across the country are pinning their hopes on the latest GDP growth numbers for a turnaround in the economy. Earlier last week, the government announced the GDP growth for the second quarter ending September at 6.3 per cent, signalling an economic recovery. In fact, India’s economic growth rate rose in Q2, after a five-quarter decline. Destocking by businesses during the first quarter of 2017-18 due to GST fears had ...
 Rediff.com2 weeks ago
Business Standard

Cadila Healthcare's Q2 net up 33% to Rs 503 cr

Cadila Healthcare Limited, also known as Zydus Cadila, reported a net profit growth of 33 per cent at Rs 503 crore in second quarter ended September 30, 2017, up from roughly Rs 378 crore for the said period last year.While total income from operations grew ...
 Business Standard1 month ago Cadila Healthcare net profit jumps 33% in Q2 on strong US India formulation sales  Money Control1 month ago

FICCI President-led CEO delegation to accompany Jaitley to Bangladesh

A high-powered business delegation led by Pankaj Patel, President, FICCI and Chairman and Managing Director, Zydus Cadila - Cadila Healthcare will accompany Finance Minister Arun Jaitley on his visit to Bangladesh on October 3 and 4, to enhance bilateral ...
 Business Standard2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less